Linde Therapeutic Solutions will be showcasing the medical industry’s first fixed-concentration nitrous oxide/oxygen (N2O/O2) therapy innovation in over 20 years at a specialist event next week.
The SEDARA® Gas Mixer System will be unveiled at the American College of Emergency Physicians (ACEP) Annual Scientific Assembly to be held at the Washington State Convention & Trade Centre in Seattle, Washington from 14th -16th October.
The system is an innovative technology designed for consistent, controlled delivery of N2O/O2 therapy, and is intended to aid procedural pain management associated with short-duration emergency and planned procedures.
Delivering a fixed 50/50 mixture of nitrous oxide and oxygen, the SEDARA® system eliminates the complexities and risks associated with titration to adjust the gas concentrations. The device provides an option uniquely suited to the emergency department, where effective pain management, time, and efficiency are critical.
Mendy Hansen, Director of Marketing for Linde Therapeutic Solutions, said of the innovation, “N2O/O2 mixtures have been used in dental and operating room applications for decades. The SEDARA® System, however, is specifically designed for use in short-term procedures conducted outside the operating room.”
“Users report success with the System in many clinical settings including emergency departments, burn units, and urology clinics. The System offers patients compassionate needle-free N2O/O2 administration, which translates into rapid pain relief that minimises trauma, struggle, and physical restraint – all of which help to free up precious time for physicians and staff. ”
Linde Therapeutic Solutions is a business unit of Linde Gas North America LLC.